Contact
Please use this form to send email to PR contact of this press release:
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
TO:
Please use this form to send email to PR contact of this press release:
Theratechnologies Receives FDA Agreement to Amended Trial Protocol for its Lead PDC Candidate Sudocetaxel Zendusortide
TO: